JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB262871

Anti-p19 INK4d antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal p19 INK4d antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human Cyclin-dependent kinase 4 inhibitor D aa 50-150.

View Alternative Names

Cyclin-dependent kinase 4 inhibitor D, p19-INK4d, CDKN2D

1 Images
Immunocytochemistry/ Immunofluorescence - Anti-p19 INK4d antibody (AB262871)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-p19 INK4d antibody (AB262871)

PFA-fixed, Triton X-100 permeabilized human A-431 cells stained for p19 INK4d (green) using ab262871 at 4 µg/ml in ICC/IF.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human Cyclin-dependent kinase 4 inhibitor D aa 50-150. The exact immunogen used to generate this antibody is proprietary information.

P55273

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1-4 µg/mL", "ICCIF-species-notes": "<p>Fixation/Permeabilization: PFA/Triton X-100</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

P19 INK4d also known as CDKN2D is a cyclin-dependent kinase inhibitor with a molecular weight of approximately 19 kDa. It belongs to the INK4 family of proteins and primarily functions to inhibit cyclin-dependent kinases (CDK4 and CDK6) playing an important role in cell cycle regulation by halting the cell cycle in the G1 phase. p19 INK4d is expressed in various tissues including the brain and endocrine organs highlighting its widespread physiological importance. The inhibition of CDK4/6 leads to the prevention of uncontrolled cell proliferation which is a hallmark of cancer.
Biological function summary

The p19 protein exerts its effects by tightly binding to CDK4 and CDK6 forming a complex that impedes their kinase activity. This interaction results in the prevention of the phosphorylation of the retinoblastoma protein (pRb) a critical step required for cell cycle progression from G1 to S phase. In doing so p19 INK4d maintains cellular growth control and prevents the transition into unchecked cell division. The regulation of pRb is vital for the prevention of cancerous growth as phosphorylated pRb releases E2F transcription factors that drive S phase entry and DNA synthesis.

Pathways

The activity of p19 INK4d influences the retinoblastoma (Rb) pathway one of the major pathways governing cell cycle control. The Rb pathway regulates the transcriptional repression of E2F target genes associated with cell cycle progression. Besides its interaction with Rb p19 INK4d is also connected with the p53 pathway which oversees cellular responses to DNA damage and stress. This links p19 INK4d indirectly to proteins like the MDM2 and p21 where these pathways intersect to coordinate cell cycle arrest mechanisms.

Dysregulation or mutations in p19 INK4d relate to certain cancers such as glioblastoma and sarcoma. Alterations impacting the function or expression levels of this protein can bypass its inhibitory role on CDK4/6 facilitating unrestrained cell proliferation. Moreover the p19 protein's connection to the retinoblastoma protein implicates it in diseases where Rb function is compromised as seen in some retinoblastomas. Understanding these relationships helps in elucidating the role of p19 INK4d in tumorigenesis and potentially offers insight into therapeutic interventions targeting the CDK4/6 axis in cancer treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Interacts strongly with CDK4 and CDK6 and inhibits them.
See full target information Cyclin-dependent kinase 4 inhibitor D

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Nature aging 1:1107-1116 PubMed35531351

2021

Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology.

Applications

Unspecified application

Species

Unspecified reactive species

Shiva Kazempour Dehkordi,Jamie Walker,Eric Sah,Emma Bennett,Farzaneh Atrian,Bess Frost,Benjamin Woost,Rachel E Bennett,Timothy C Orr,Yingyue Zhou,Prabhakar S Andhey,Marco Colonna,Peter H Sudmant,Peng Xu,Minghui Wang,Bin Zhang,Habil Zare,Miranda E Orr
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com